CARDIOVASCULAR RISK ESTIMATION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH BIOLOGICS OR C-DMARDS

被引：0
|
作者：
Mole, Evangelia [1 ]
Gazi, Sousana [1 ]
Moschou, Dimitra [1 ]
Mpaili, Georgia [1 ]
Theodorakopoulos, Stavros [1 ]
Zoupidou, Konstantina [1 ]
Kontodimopoulos, Nikolaos [2 ]
机构：
[1] KAT Gen Hosp Attica, Dept Rheumatol, Athens, Greece
[2] KAT Gen Hosp Attica, Div Management, Athens, Greece
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.2504
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0323
引用
收藏
页码：1620 / 1620
页数：1
相关论文
共 50 条
  • [31] Cardiovascular risk in patients with rheumatoid arthritis
    Kim Lauper
    Cem Gabay
    Seminars in Immunopathology, 2017, 39 : 447 - 459
  • [32] Cardiovascular Risk in Patients with Rheumatoid Arthritis
    Mahbouba, Jguirim
    Amira, Mhenni
    Mongi, Touzi
    Linda, Mani
    Raja, Alaya
    Saoussen, Zrour
    Ismail, Bejia
    Naceur, Bergaoui
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S30 - S30
  • [33] Cardiovascular risk in patients with rheumatoid arthritis
    Lauper, Kim
    Gabay, Cem
    SEMINARS IN IMMUNOPATHOLOGY, 2017, 39 (04) : 447 - 459
  • [34] THE DYNAMICS OF MENTAL DISORDERS FREQUENCY IN COMPLEX DMARDS, BIOLOGICS AND ANTIDEPRESSANTS TREATMENT OF RHEUMATOID ARTHRITIS PATIENTS
    Abramkin, A.
    Lisitsyna, T.
    Veltishchev, D.
    Seravina, O.
    Kovalevskaya, O.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 249 - 249
  • [35] Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: an updated meta-analysis
    Olsen, Catherine M.
    Green, Adele C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (08)
  • [36] Cardiovascular risk estimation and management in rheumatoid arthritis: comment on the EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis
    Ozen, G.
    Direskeneli, H.
    Inanc, N.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (06) : S16 - S17
  • [37] Cancer risk with biologic DMARDs in rheumatoid arthritis
    Reactions Weekly, 2017, 1672 (1) : 11 - 11
  • [38] Aseptic pyomyositis in rheumatoid arthritis treated with corticosteroid and DMARDs
    Karmacharya, Sudhir
    Shrestha, Adheep Arun
    Nakarmi, Shweta
    Bhochhibhoya, Manisha
    Vaidya, Binit
    OXFORD MEDICAL CASE REPORTS, 2024, 2024 (06): : 245 - 248
  • [39] COMPARISON OF CARDIOVASCULAR RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH BIOLOGICS VERSUS METHOTREXATE: RESULTS AT 24-MONTHS OF FOLLOW-UP
    Khraishi, M.
    Stutz, M.
    Lewis, A.
    Molta, C.
    Rampakakis, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 539 - 539
  • [40] Inflammatory immune cell responses and Toll-like receptor expression in synovial tissues in rheumatoid arthritis patients treated with biologics or DMARDs
    Takakubo, Yuya
    Tamaki, Yasunobu
    Hirayama, Tomoyuki
    Iwazaki, Kiyoshi
    Sasaki, Kan
    Sasaki, Akiko
    Ohki, Hiroharu
    Takakubo, Noe
    Konttinen, Yrjo T.
    Takagi, Michiaki
    CLINICAL RHEUMATOLOGY, 2013, 32 (06) : 853 - 861
12345